MENU
+Compare
MRK
Stock ticker: NYSE
AS OF
Jun 24 closing price
Price
$80.32
Change
+$0.16 (+0.20%)
Capitalization
331.75B

MRK Merck & Co Forecast, Technical & Fundamental Analysis

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MRK with price predictions
Jun 23, 2025

Aroon Indicator for MRK shows an upward move is likely

MRK's Aroon Indicator triggered a bullish signal on June 23, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 236 similar instances where the Aroon Indicator showed a similar pattern. In of the 236 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on MRK as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRK just turned positive on May 21, 2025. Looking at past instances where MRK's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

MRK moved above its 50-day moving average on June 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MRK crossed bullishly above the 50-day moving average on June 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where MRK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

MRK broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.826) is normal, around the industry mean (5.632). MRK's P/E Ratio (935.643) is considerably higher than the industry average of (48.974). Projected Growth (PEG Ratio) (0.105) is also within normal values, averaging (3.004). Dividend Yield (0.023) settles around the average of (0.161) among similar stocks. P/S Ratio (5.549) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MRK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRK is expected to report earnings to fall 7.21% to $2.06 per share on July 29

Merck & Co MRK Stock Earnings Reports
Q2'25
Est.
$2.06
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.12
The last earnings report on April 24 showed earnings per share of $2.22, beating the estimate of $2.14. With 15.91M shares outstanding, the current market capitalization sits at 331.75B.
A.I.Advisor
published Dividends

MRK is expected to pay dividends on July 08, 2025

Merck & Co MRK Stock Dividends
A dividend of $0.81 per share will be paid with a record date of July 08, 2025, and an ex-dividend date of June 16, 2025. The last dividend of $0.81 was paid on April 07. Read more...
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SG12.820.55
+4.48%
Sweetgreen
C79.360.91
+1.16%
Citigroup
HALO52.80-0.01
-0.02%
Halozyme Therapeutics
IFRX0.79N/A
-0.28%
InflaRx NV
ABSI2.76-0.03
-1.08%
Absci Corp

MRK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.33%
PFE - MRK
46%
Loosely correlated
+0.25%
AMGN - MRK
42%
Loosely correlated
-5.84%
AZN - MRK
42%
Loosely correlated
+0.99%
BIIB - MRK
41%
Loosely correlated
-1.79%
ABBV - MRK
41%
Loosely correlated
-0.93%
More